Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks upAlzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.[Collection]

Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.https://www.cnbc.com/2024/04/24/biogen-biib-earnings-q1-2024-.html